NR2E1 Antibody (monoclonal) (M06)
Mouse monoclonal antibody raised against a partial recombinant NR2E1.
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| IF |
---|---|
Primary Accession | Q9Y466 |
Other Accession | NM_003269 |
Reactivity | Human |
Host | mouse |
Clonality | Monoclonal |
Isotype | IgG2a Kappa |
Clone Names | 4D2 |
Calculated MW | 42589 Da |
Gene ID | 7101 |
---|---|
Other Names | Nuclear receptor subfamily 2 group E member 1, Nuclear receptor TLX, Protein tailless homolog, Tll, hTll, NR2E1, TLX |
Target/Specificity | NR2E1 (NP_003260, 249 a.a. ~ 342 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | NR2E1 Antibody (monoclonal) (M06) is for research use only and not for use in diagnostic or therapeutic procedures. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
References
The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation. Liu HK, et al. Genes Dev, 2010 Apr 1. PMID 20360385.Transcriptional activation of NAD+-dependent protein deacetylase SIRT1 by nuclear receptor TLX. Iwahara N, et al. Biochem Biophys Res Commun, 2009 Sep 4. PMID 19555662.A common variant in DRD3 receptor is associated with autism spectrum disorder. de Krom M, et al. Biol Psychiatry, 2009 Apr 1. PMID 19058789.Transrepressive function of TLX requires the histone demethylase LSD1. Yokoyama A, et al. Mol Cell Biol, 2008 Jun. PMID 18391013.Initial association of NR2E1 with bipolar disorder and identification of candidate mutations in bipolar disorder, schizophrenia, and aggression through resequencing. Kumar RA, et al. Am J Med Genet B Neuropsychiatr Genet, 2008 Sep 5. PMID 18205168.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.